BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34336728)

  • 1. Predictors of Successful Yttrium-90 Radioembolization Bridging or Downstaging in Patients with Hepatocellular Carcinoma.
    Villalobos A; Wagstaff W; Guo M; Zhang J; Bercu Z; Whitmore MJ; Cristescu MM; Majdalany BS; Wedd J; Akce M; Magliocca J; Kokabi N
    Can J Gastroenterol Hepatol; 2021; 2021():9926704. PubMed ID: 34336728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yttrium-90 Radioembolization for Hepatocellular Carcinoma Prior to Liver Transplantation.
    Ettorre GM; Levi Sandri GB; Laurenzi A; Colasanti M; Meniconi RL; Lionetti R; Santoro R; Lepiane P; Sciuto R; Pizzi G; Cianni R; Golfieri R; D'Offizi G; Pellicelli AM; Antonini M; Vennarecci G
    World J Surg; 2017 Jan; 41(1):241-249. PubMed ID: 27495316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver Transplantation Following Yttrium-90 Radioembolization: 15-Year Experience in 207-Patient Cohort.
    Gabr A; Kulik L; Mouli S; Riaz A; Ali R; Desai K; Mora RA; Ganger D; Maddur H; Flamm S; Boike J; Moore C; Thornburg B; Alasadi A; Baker T; Borja-Cacho D; Katariya N; Ladner DP; Caicedo JC; Lewandowski RJ; Salem R
    Hepatology; 2021 Mar; 73(3):998-1010. PubMed ID: 32416631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trans-arterial radio-embolization: a new chance for patients with hepatocellular cancer to access liver transplantation, a world review.
    Levi Sandri GB; Ettorre GM; Giannelli V; Colasanti M; Sciuto R; Pizzi G; Cianni R; D'Offizi G; Antonini M; Vennarecci G; Lucatelli P
    Transl Gastroenterol Hepatol; 2017; 2():98. PubMed ID: 29264436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yttrium-90 Radioembolization for BCLC Stage C Hepatocellular Carcinoma Comparing Child-Pugh A Versus B7 Patients: Are the Outcomes Equivalent?
    Zu Q; Schenning RC; Jahangiri Y; Tomozawa Y; Kolbeck KJ; Kaufman JA; Al-Hakim R; Naugler WE; Nabavizadeh N; Kardosh A; Billingsley KG; Mayo SC; Orloff SL; Enestvedt KK; Maynard E; Ahn J; Lhewa D; Farsad K
    Cardiovasc Intervent Radiol; 2020 May; 43(5):721-731. PubMed ID: 32140840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging.
    Affonso BB; Galastri FL; da Motta Leal Filho JM; Nasser F; Falsarella PM; Cavalcante RN; de Almeida MD; Felga GEG; Valle LGM; Wolosker N
    World J Gastroenterol; 2019 Oct; 25(37):5687-5701. PubMed ID: 31602168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma with macrovascular invasion treated with yttrium-90 radioembolization prior to transplantation.
    Levi Sandri GB; Ettorre GM; Colasanti M; De Werra E; Mascianà G; Ferraro D; Tortorelli G; Sciuto R; Lucatelli P; Pizzi G; Visco-Comandini U; Vennarecci G
    Hepatobiliary Surg Nutr; 2017 Feb; 6(1):44-48. PubMed ID: 28261594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.
    Salem R; Gordon AC; Mouli S; Hickey R; Kallini J; Gabr A; Mulcahy MF; Baker T; Abecassis M; Miller FH; Yaghmai V; Sato K; Desai K; Thornburg B; Benson AB; Rademaker A; Ganger D; Kulik L; Lewandowski RJ
    Gastroenterology; 2016 Dec; 151(6):1155-1163.e2. PubMed ID: 27575820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of yttrium-90 microsphere radioembolization of hepatocellular carcinoma as downstaging and bridge before liver transplantation: a case report.
    Khalaf H; Alsuhaibani H; Al-Sugair A; Al-Mana H; Al-Mutawa A; Al-Kadhi Y; Al-Sebayel M
    Transplant Proc; 2010 Apr; 42(3):994-8. PubMed ID: 20430224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of survival according to kinetic changes of cytokines and hepatitis status following radioembolization with yttrium-90 microspheres.
    Liu CA; Lee IC; Lee RC; Chen JL; Chao Y; Hou MC; Huang YH
    J Formos Med Assoc; 2021 Apr; 120(4):1127-1136. PubMed ID: 32978044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioembolization Super Survivors: Extended Survival in Non-operative Hepatocellular Carcinoma.
    Gordon AC; Gabr A; Riaz A; Uddin OM; Abouchaleh N; Ali R; Kallini J; Salem R; Lewandowski RJ
    Cardiovasc Intervent Radiol; 2018 Oct; 41(10):1557-1565. PubMed ID: 29948005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating and downstaging hepatocellular carcinoma in the caudate lobe with yttrium-90 radioembolization.
    Ibrahim SM; Kulik L; Baker T; Ryu RK; Mulcahy MF; Abecassis M; Salem R; Lewandowski RJ
    Cardiovasc Intervent Radiol; 2012 Oct; 35(5):1094-101. PubMed ID: 22069121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yttrium-90 Radioembolization: Current Indications and Outcomes.
    Hamad A; Aziz H; Kamel IR; Diaz DA; Pawlik TM
    J Gastrointest Surg; 2023 Mar; 27(3):604-614. PubMed ID: 36547759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes.
    Salem R; Lewandowski RJ; Mulcahy MF; Riaz A; Ryu RK; Ibrahim S; Atassi B; Baker T; Gates V; Miller FH; Sato KT; Wang E; Gupta R; Benson AB; Newman SB; Omary RA; Abecassis M; Kulik L
    Gastroenterology; 2010 Jan; 138(1):52-64. PubMed ID: 19766639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of Use of Y90 as a Bridge to Liver Resection and Transplantation in Hepatocellular Carcinoma.
    Qadan M; Fong ZV; Delman AM; Gabr A; Salem R; Shah SA
    J Gastrointest Surg; 2021 Oct; 25(10):2690-2699. PubMed ID: 34345997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient Selection and Clinical Outcomes of Y90 in Hepatocellular Carcinoma.
    Wehrenberg-Klee E; Gandhi RT; Ganguli S
    Tech Vasc Interv Radiol; 2019 Jun; 22(2):70-73. PubMed ID: 31079713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of Successful Downstaging of Hepatocellular Carcinoma Outside Milan Criteria.
    Murali AR; Romero-Marrero C; Miller C; Aucejo F; Levitin A; Gill A; McLennan G; Karuppasamy K; Zein NN; Lopez R; Menon KV
    Transplantation; 2016 Nov; 100(11):2391-2397. PubMed ID: 27780187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can volumetric ADC measurement help predict response to Y90 radioembolization in HCC?
    Vouche M; Salem R; Lewandowski RJ; Miller FH
    Abdom Imaging; 2015 Aug; 40(6):1471-80. PubMed ID: 25412868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yttrium-90 radioembolization as a bridge to liver transplantation: a single-institution experience.
    Tohme S; Sukato D; Chen HW; Amesur N; Zajko AB; Humar A; Geller DA; Marsh JW; Tsung A
    J Vasc Interv Radiol; 2013 Nov; 24(11):1632-8. PubMed ID: 24160821
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Abouchaleh N; Gabr A; Ali R; Al Asadi A; Mora RA; Kallini JR; Mouli S; Riaz A; Lewandowski RJ; Salem R
    J Nucl Med; 2018 Jul; 59(7):1042-1048. PubMed ID: 29217739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.